芬太尼和其他新型精神活性合成阿片类药物. 预防和治疗的挑战
Damaris Albores-García1, Silvia L Cruz1
1Department of Pharmacobiology, Center for Research and Advanced Studies (Cinvestav), National Polytechnic Institute, Mexico City, Mexico.
概括
新型精神活性阿片类药物 (NPO) 是强大的合成药物,导致正在进行的阿片类药物危机. 本综述详细介绍了它们的影响,分类以及预防和治疗的挑战.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 公共卫生 公共卫生
背景情况:
- 合成阿片类药物,特别是新型精神活性阿片类药物 (NPO),是导致阿片类药物危机的一个主要全球问题.
- 无毒药物是一种新兴精神活性物质 (NPS) 的子集,最近在非法毒品市场出现.
- 这些物质,包括芬太尼及其类似物,模仿吗啡的作用,但具有致命呼吸抑制的高风险.
研究的目的:
- 提供一个全面的概述主要的NPOs的系统和分子效应.
- 为了分类NPO并详细说明它们的药理性质.
- 总结墨西哥关于非营利组织使用的有限文献,并讨论预防和治疗方面的挑战.
主要方法:
- 关于NPOs系统和分子影响的文献综述.
- 根据化学结构和来源对NPOs进行分类.
- 对药理性质的检查,包括镇痛,高兴感和呼吸抑制.
- 对常常滥用的药物中NPO改的审查.
- 墨西哥非营利组织的流行和影响的总结.
主要成果:
- 包括芬太尼类同类物和非芬太尼化合物 (如兄弟啡和埃托尼塔) 在内的NPOs表现出强大的吗啡类效应.
- 临床和兽用芬太尼衍生物 (芬太尼,阿尔芬太尼,苏芬太尼,雷米芬太尼,卡芬太尼) 与非医疗类别一起讨论.
- 非营利组织越来越多地被用作非法毒品的染剂,使其的检测和管理变得复杂.
- 关于NPO使用模式和墨西哥公共卫生影响的数据有限.
结论:
- 非营利性组织由于其强度和广泛的非法使用,对公共卫生构成重大挑战.
- 迫切需要有效的预防和治疗策略来应对NPO危机.
- 需要进一步的研究来了解NPO的流行病学,特别是在墨西哥等地区.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
343
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
343
Opioid Analgesics: Morphine and Other Natural Cogeners
300
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
300
Analgesia and Pain Management
665
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
665
Prescription, Nonprescription and Orphan Drugs
778
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
778
Drug Abuse and Addiction: Pharmacological Phenomena
544
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
544
Drug Control Governance: Regulatory Bodies and Their Impact
189
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
189


